IMPLANT SITE HAEMATOMA

This adverse event was reported 244 times

These drugs are most commonly taken by patients reporting IMPLANT SITE HAEMATOMA:

# Drug Count
0 ETONOGESTREL 55
1 RIVAROXABAN 32
2 ASPIRIN 24
3 ASPIRIN 325 MG 22
4 ASPIRIN 81 MG 22
5 BACLOFEN 22
6 CLOPIDOGREL 22
7 CLOPIDOGREL BISULFATE 22
8 WARFARIN 15
9 FUROSEMIDE 13
See all common drugs associated with IMPLANT SITE HAEMATOMA

IMPLANT SITE HAEMATOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACLOFEN INJECTION 9 0.0029
1 DANTROLENE SODIUM 2 0.0017
2 ETONOGESTREL 55 0.0010
3 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 7 0.0009
4 ZICONOTIDE ACETATE 2 0.0008
5 BUPIVACAINE 7 0.0007
6 CEFAZOLIN SODIUM 7 0.0006
7 DOBUTAMINE 2 0.0005
8 DUTASTERIDE 3 0.0004
9 BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 1 0.0003
See all drugs enriched for association with IMPLANT SITE HAEMATOMA

IMPLANT SITE HAEMATOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 gamma-Aminobutyric Acid-ergic Agonist [EPC] 31 0.0003
1 Progestin [EPC] 57 0.0002
2 P2Y12 Platelet Inhibitor [EPC] 20 0.0002
3 Factor Xa Inhibitor [EPC] 43 0.0002
4 Asparagine-specific Enzyme [EPC] 2 0.0001
5 Glinide [EPC] 1 0.0001
6 Central alpha-2 Adrenergic Agonist [EPC] 6 0.0001
7 Anti-anginal [EPC] 1 0.0001
8 Amide Local Anesthetic [EPC] 7 0.0001
9 Vitamin D Analog [EPC] 1 0.0001
See all drug classes enriched for association with IMPLANT SITE HAEMATOMA